Search

Your search keyword '"Simonetto, Douglas"' showing total 674 results
Start Over Author "Simonetto, Douglas"
674 results on '"Simonetto, Douglas"'

2. Liver disease and transplantation in telomere biology disorders: An international multicenter cohort.

Author

Wang, YunZu, Kaj-Carbaidwala, Batul, Lane, Adam, Agarwal, Suneet, Beier, Fabian, Bertuch, Alison, Borovsky, Kristin, Brennan, Steven, Calado, Rodrigo, Catto, Luiz, Dufour, Carlo, Ebens, Christen, Fioredda, Francesca, Giri, Neelam, Gloude, Nicholas, Goldman, Frederick, Hertel, Paula, Himes, Ryan, Keel, Sioban, Koura, Divya, Kratz, Christian, Kulkarni, Sakil, Liou, Iris, Nakano, Taizo, Nastasio, Silvia, Niewisch, Marena, Penrice, Daniel, Sasa, Ghadir, Savage, Sharon, Simonetto, Douglas, Ziegler, David, Miethke, Alexander, and Myers, Kasiani

Subjects
Humans, Liver Transplantation, Female, Male, Retrospective Studies, Adult, Middle Aged, Telomere, Adolescent, Liver Diseases, Young Adult, Child, Treatment Outcome, Child, Preschool
Abstract

BACKGROUND: Patients with telomere biology disorders (TBD) develop hepatic disease, including hepatitis, cirrhosis, and hepatopulmonary syndrome. No specific treatment exists for TBD-related liver disease, and the role of liver transplantation (LT) remains controversial. Our study objectives were to describe the clinical characteristics, management, and outcomes in patients with TBD-related liver disease, and their LT outcomes. METHODS: Data from 83 patients with TBD-associated liver disease were obtained from 17 participating centers in the Clinical Care Consortium of Telomere-Associated Ailments and by self-report for our retrospective, multicenter, international cohort study. RESULTS: Group A (Advanced) included 40 patients with advanced liver disease. Of these, 20 underwent LT (Group AT). Group M (Mild) included 43 patients not warranting LT evaluation, none of whom were felt to be medically unfit for liver transplantation. Supplemental oxygen requirement, pulmonary arteriovenous malformation, hepatopulmonary syndrome, and higher bilirubin and international normalized ratio values were associated with Group A. Other demographics, clinical manifestations, and laboratory findings were similar between groups. Six group A patients were declined for LT; 3 died on the waitlist. Median follow-up post-LT was 2.9 years (range 0.6-13.2 y). One-year survival post-LT was 73%. Median survival post-LT has not been reached. Group AT patients had improved survival by age compared to all nontransplant patients (log-rank test p = 0.02). Of 14 patients with pretransplant hypoxemia, 8 (57%) had improved oxygenation after transplant. CONCLUSIONS: LT recipients with TBD do not exhibit excessive posttransplant mortality, and LT improved respiratory status in 57%. A TBD diagnosis should not exclude LT consideration.

Published
2024

10. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

Author

Boike, Justin, Thornburg, Bartley, Asrani, Sumeet, Fallon, Michael, Fortune, Brett, Izzy, Manhal, Verna, Elizabeth, Abraldes, Juan, Allegretti, Andrew, Bajaj, Jasmohan, Biggins, Scott, Darcy, Michael, Farr, Maryjane, Farsad, Khashayar, Garcia-Tsao, Guadalupe, Hall, Shelley, Jadlowiec, Caroline, Krowka, Michael, Laberge, Jeanne, Lee, Edward, Mulligan, David, Nadim, Mitra, Northup, Patrick, Salem, Riad, Shatzel, Joseph, Shaw, Cathryn, Simonetto, Douglas, Susman, Jonathan, Kolli, K, and VanWagner, Lisa

Subjects
Ascites, Cirrhosis, Complications, Consensus Statement, End-Stage Liver Disease, Guidance Document, TIPS Procedure, Variceal Bleeding, Ascites, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage, Humans, Hypertension, Portal, Portasystemic Shunt, Transjugular Intrahepatic, Treatment Outcome
Abstract

Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and mortality. Despite few high-quality randomized controlled trials to guide therapeutic decisions, transjugular intrahepatic portosystemic shunt (TIPS) creation has emerged as a crucial therapeutic option to treat complications of portal hypertension. In North America, the decision to perform TIPS involves gastroenterologists, hepatologists, and interventional radiologists, but TIPS creation is performed by interventional radiologists. This is in contrast to other parts of the world where TIPS creation is performed primarily by hepatologists. Thus, the successful use of TIPS in North America is dependent on a multidisciplinary approach and technical expertise, so as to optimize outcomes. Recently, new procedural techniques, TIPS stent technology, and indications for TIPS have emerged. As a result, practices and outcomes vary greatly across institutions and significant knowledge gaps exist. In this consensus statement, the Advancing Liver Therapeutic Approaches group critically reviews the application of TIPS in the management of portal hypertension. Advancing Liver Therapeutic Approaches convened a multidisciplinary group of North American experts from hepatology, interventional radiology, transplant surgery, nephrology, cardiology, pulmonology, and hematology to critically review existing literature and develop practice-based recommendations for the use of TIPS in patients with any cause of portal hypertension in terms of candidate selection, procedural best practices and, post-TIPS management; and to develop areas of consensus for TIPS indications and the prevention of complications. Finally, future research directions are identified related to TIPS for the management of portal hypertension.

Published
2022

13. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

Author

Chalasani, Naga, Patidar, Kavish R., Vuppalanchi, Raj, Samala, Niha, Yoder, Lindsey, Nephew, Lauren, Shah, Vijay H., Simonetto, Douglas A., Kamath, Patrick, Vargas, Hugo E., Yang, Liu, Dasarathy, Srinivasan, Welch, Nicole, Bellar, Annette, Attaway, Amy, Dasarathy, Jaividhya, Growley, Ashley, Streem, David, Nagy, Laura E., Mitchell, Mack C., Herlong, H. Franklin, Kerr, Thomas, Cotter, Thomas, Sanyal, Arun, O'Connor, Sara, Luketic, Velimir, Asgharpour, Amon, Taylor, Stephanie, McClain, Craig J., Vatsalya, Vatsalya, Jophlin, Loretta, Cave, Matt, Jha, Suman Kumar, Marsano, Luis, Barve, Ashutosh, Frimodig, Jane, Bataller, Ramon, Ravi, Samhita, Behari, Jaideep, Shivanekar, Sharvari, Novelli, Paula, Duarte-Rojo, Andres, Jonassaint, Naudia, Szabo, Gyongyi, Curry, Jiang, Zhenghui G., Agarwal, Ushma, Hazel, Mia, Schnabl, Bernd, Gawrieh, Samer, Tu, Wanzhu, Kamath, Patrick S., Chalasani, Naga P., Tang, Qing, Radaeva, Svetlana, Barton, Bruce, and Sanyal, Arun J.

Published
2024
Full Text
View/download PDF

14. Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes

Author

Díaz, Luis Antonio, Fuentes-López, Eduardo, Idalsoaga, Francisco, Ayares, Gustavo, Corsi, Oscar, Arnold, Jorge, Cannistra, Macarena, Vio, Danae, Márquez-Lomas, Andrea, Ramirez-Cadiz, Carolina, Medel, María Paz, Hernandez-Tejero, María, Ferreccio, Catterina, Lazo, Mariana, Roblero, Juan Pablo, Cotter, Thomas G., Kulkarni, Anand V., Kim, Won, Brahmania, Mayur, Louvet, Alexandre, Tapper, Elliot B., Dunn, Winston, Simonetto, Douglas, Shah, Vijay H., Kamath, Patrick S., Lazarus, Jeffrey V., Singal, Ashwani K., Bataller, Ramon, Arrese, Marco, and Arab, Juan Pablo

Published
2024
Full Text
View/download PDF

15. Expert opinion on bleeding risk from invasive procedures in cirrhosis

Author

Alix Riescher-Tuczkiewicz, Stephen H. Caldwell, Patrick S. Kamath, Erica Villa, Pierre-Emmanuel Rautou, Afdhal Nezam H, Ageno Walter, Bianchini Marcello, Blasi Annabel, Caldwell Stephen H, Callaway Mark, Cardenas Andres, Darwish Murad Sarwa, De Gottardi Andrea, De Pietri Lesley, De Raucourt Emmanuelle, Dell'Era Alessandra, Denys Alban, Elkrief Laure, Garcia-Pagan Juan-Carlos, Garcia-Tsao Guadalupe, Gatt Alexander, Giannini Edoardo G, Golfieri Rita, Greenberg Charles S, Hernández-Gea Virginia, Heydtmann Mathis, Intagliata Nicolas M, Kamath Patrick S, Lester Will, Magnusson Maria, Neuberger James, Northup Patrick G, O'Leary Jacqueline G, Patton Heather, Peck-Radosavljevic Markus, Pillai Anjana, Plessier Aurélie, Rautou Pierre-Emmanuel, Ripoll Cristina, Roberts Lara N, Sarwar Ammar, Senzolo Marco, Shukla Akash, Simioni Paolo, Simonetto Douglas A, Singal Ashwani K, Soto Robin, Stine Jonathan G, Tapper Elliot B, Thabut Dominique, Thachil Jecko, Tomescu Dana, Tripathi Dhiraj, Tsochatzis Emmanuel A, Villa Erica, and Valla Dominique

Subjects
haemorrhage, coagulation, haemostasis, biopsy, anticoagulant, procedural related bleeding, Diseases of the digestive system. Gastroenterology, RC799-869
Abstract

Background & Aims: Despite several recent international guidelines, no consensus exists on the bleeding risk nor haemostatic parameter thresholds that define the safety of invasive procedures in patients with cirrhosis. The aim of this study was to establish a position paper on the bleeding risk associated with invasive procedures in patients with cirrhosis among the experts involved in various guidelines. Methods: All experts involved in recent guidelines on the management of invasive procedures in patients with cirrhosis were invited to classify 80 procedures as ''high risk'' or ''low risk'' with respect to bleeding. Procedures were considered high risk when the estimated risk of major bleeding was 1.5% or more, or when even minor bleeding might lead to significant morbidity or death. The experts were also asked to choose safety thresholds for laboratory test values at which elective invasive procedures could be safely performed. The predetermined threshold considered as “consensus” was ≥75% agreement. Results: Fifty-two experts participated in the study. Out of 80 procedures, a consensus opinion was reached for 52 procedures (65%): 17 procedures were classified as “high risk”, primarily interventional endoscopic procedures, percutaneous organ biopsies, or procedures involving the central nervous system; and 35 as “low risk”, primarily “diagnostic” procedures. The lowest platelet counts at which performance of a low-risk procedure or a high-risk procedure/surgery were deemed acceptable were 30 × 109/L and 50 × 109/L, respectively. Experts did not believe that international normalised ratio should be considered before performing low-risk procedures; 71% also indicated that it should not be considered before performing high-risk procedures. Conclusions: This experience-based classification may be helpful to refine future study designs and to guide clinical decision making regarding invasive procedures in patients with cirrhosis. Impact and implications: Several risk classifications and management guidelines for invasive procedures in patients with cirrhosis have been proposed, but with conflicting recommendations. By providing a position paper, based on the opinion of a broad panel of experts, on the bleeding risk associated with 52 invasive procedures in patients with cirrhosis, this survey will help to provide a framework for future study design. The consensus on platelet count, international normalised ratio, fibrinogen and activated partial thromboplastin time identified in this survey will inform physicians regarding the laboratory test values considered acceptable by the experts prior to the performance of an elective invasive procedure in patients with cirrhosis.

Published
2024
Full Text
View/download PDF

18. Conceptualization of Remote Patient Monitoring Program for Patients with Complex Medical Illness on Hospital Dismissal

Author

Charkviani, Mariam, Simonetto, Douglas A., Ahrens, Desiree J., Amundson, Rachel H., Bell, Sarah J., Busch, Joel J., Caine, Natalie A., Cleveland, Eric J., Coelho-Prabhu, Nayantara, Barreto, Erin F., Daniels, Craig E., DeZutter, Meredith A., Ebbert, Jon O., Kattah, Andrea G., Kohler, Christopher M., Leuenberger, Angela M., Pahl, Dominick F., Reinschmidt, Karen J., and Philpot, Lindsey M.

Published
2023
Full Text
View/download PDF

21. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US

Author

Patidar, Kavish R., Belcher, Justin M., Regner, Kevin R., St. Hillien, Shelsea A., Simonetto, Douglas A., Asrani, Sumeet K., Neyra, Javier A., Sharma, Pratima, Velez, Juan Carlos Q., Wadei, Hani, Nadim, Mitra K., Chung, Raymond T., Seethapathy, Ritu, Parada, Xavier Vela, Ouyang, Tianqi, Ufere, Nneka N., Robinson, Jevon E., McLean Diaz, Paige, Wilechansky, Robert M., Przybyszewski, Eric M., Smith, Thomas N., Ali, Arzina Aziz, Orman, Eric S., Schulz, Philipp, Siddiqui, Salaah M., Shabbir, Rehma, Liu, Lucas J., Cama-Olivares, Augusto, Flannery, Alexander H., Baker, Megan L., Gunasekaran, Deepthi, Aswine, Adeline, Issa, Rafik, Li, Jay, Verma, Shreya, Chalmers, Dustin, Varghese, Vipin, Lam, Walter, Mohamed, Muner, Kovacic, Rosemary, Gaddy, Anna, Attieh, Rose Mary, Cortes, Pedro, Semnani, Sahar, Wang, Lin, Khemichian, Saro, and Allegretti, Andrew S.

Published
2023
Full Text
View/download PDF

22. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure

Author

Al Attar, Atef, Kosari, Kambiz, Garcia, Richard, Salmastyan, Gevork, Cranford, William, Patel, Preet, Xue, Pei, Mishra, Soumya, Parks, Madison, Flocco, Gianina, Gao, Jing, Wu, Tiffany, Thanneeru, Priya, Reddy, Vikrant, Hurtado, Mariana, Mohamed, Islam, Vyhmeister, Ross, Lopez, Christine R., Campbell, Braidie, Winters, Adam C., Simpson, Mary Ann, Ying, Xiaohan, Hernaez, Ruben, Karvellas, Constantine J., Liu, Yan, Sacleux, Sophie-Caroline, Khemichian, Saro, Stein, Lance L., Shetty, Kirti, Lindenmeyer, Christina C., Boike, Justin R., Simonetto, Douglas A., Rahimi, Robert S., Jalal, Prasun K., Izzy, Manhal, Kriss, Michael S., Im, Gene Y., Lin, Ming V., Jou, Janice H., Fortune, Brett E., Cholankeril, George, Kuo, Alexander, Mahmud, Nadim, Kanwal, Fasiha, Saliba, Faouzi, Sundaram, Vinay, Artzner, Thierry, and Jalan, Rajiv

Published
2023
Full Text
View/download PDF

23. Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study

Author

Intagliata, Nicolas M., Rahimi, Robert S., Higuera-de-la-Tijera, Fatima, Simonetto, Douglas A., Farias, Alberto Queiroz, Mazo, Daniel F., Boike, Justin R., Stine, Jonathan G., Serper, Marina, Pereira, Gustavo, Mattos, Angelo Z., Marciano, Sebastian, Davis, Jessica P.E., Benitez, Carlos, Chadha, Ryan, Méndez-Sánchez, Nahum, deLemos, Andrew S., Mohanty, Arpan, Dirchwolf, Melisa, Fortune, Brett E., Northup, Patrick G., Patrie, James T., and Caldwell, Stephen H.

Published
2023
Full Text
View/download PDF

24. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis

Author

Díaz, Luis Antonio, Fuentes-López, Eduardo, Ayares, Gustavo, Idalsoaga, Francisco, Arnold, Jorge, Valverde, María Ayala, Perez, Diego, Gómez, Jaime, Escarate, Rodrigo, Villalón, Alejandro, Ramírez, Carolina A., Hernandez-Tejero, Maria, Zhang, Wei, Qian, Steve, Simonetto, Douglas A., Ahn, Joseph C., Buryska, Seth, Dunn, Winston, Mehta, Heer, Agrawal, Rohit, Cabezas, Joaquín, García-Carrera, Inés, Cuyàs, Berta, Poca, Maria, Soriano, German, Sarin, Shiv K., Maiwall, Rakhi, Jalal, Prasun K., Abdulsada, Saba, Higuera-de-la-Tijera, Fátima, Kulkarni, Anand V., Rao, P. Nagaraja, Salazar, Patricia Guerra, Skladaný, Lubomir, Bystrianska, Natália, Clemente-Sanchez, Ana, Villaseca-Gómez, Clara, Haider, Tehseen, Chacko, Kristina R., Romero, Gustavo A., Pollarsky, Florencia D., Restrepo, Juan Carlos, Castro-Sanchez, Susana, Toro, Luis G., Yaquich, Pamela, Mendizabal, Manuel, Garrido, Maria Laura, Marciano, Sebastián, Dirchwolf, Melisa, Vargas, Victor, Jiménez, César, Louvet, Alexandre, García-Tsao, Guadalupe, Roblero, Juan Pablo, Abraldes, Juan G., Shah, Vijay H., Kamath, Patrick S., Arrese, Marco, Singal, Ashwani K., Bataller, Ramon, and Arab, Juan Pablo

Published
2023
Full Text
View/download PDF

34. Forecasting Alcohol‐Related Liver Disease Mortality Trends in Younger Populations Using Advanced Time‐Series Models: A 1999–2030 Analysis.

Author

Ali, Hassam, Jahagirdar, Vinay, Blaney, Hanna, Dahiya, Dushyant Singh, Gangwani, Manesh K., Patel, Pratik, Hayat, Umar, Jaber, Fouad, Simonetto, Douglas A., and Satapathy, Sanjaya K.

Subjects
BOX-Jenkins forecasting, AGE groups, DEATH rate, YOUNG adults, TIME series analysis
Abstract

Objective: Alcohol‐related liver disease (ALD) has emerged as a significant public health concern, particularly among younger populations. ALD remains the leading cause of alcohol‐attributable deaths. This study aims to forecast ALD mortality trends up to 2030, focusing on individuals under 55 years. Methods: We utilized data from the CDC WONDER database (1999–2022) to examine ALD‐related deaths, identified by ICD‐10 codes (K70.0–K70.9). Crude mortality rates (CMRs) per 100 000 were analyzed and temporal trends were assessed using annual and average annual percent changes (APC/AAPC) with empirical quantile confidence intervals. An Autoregressive Integrated Moving Average (ARIMA) model was employed to project mortality rates until 2030, validated through time series cross‐validation. Results: From 1999 to 2022, there were 181 862 ALD‐related deaths among individuals under 55, with mortality rates increasing from 3.9 per 100 000 in 1999 to 9.7 per 100 000 in 2022 (AAPC 4.66%, 95% CI: 3.90%–5.86%). Projections suggest rates will continue to rise, reaching 14.4 per 100 000 by 2030. From 1999 to 2022, the 25–34 age group experienced the highest increase, with an AAPC of 10.27% (95% CI: 9.19%–11.35%), while the 35–44 and 45–54 age groups showed more moderate increases, with AAPCs of 5.03% and 4.38%, respectively. Projections indicate an AAPC of 3.86% for ages 25–34, 3.90% for ages 35–44, and 6.17% for ages 45–54 by 2030. Conclusion: Forecasts indicate a continued rise in ALD mortality among individuals under 55, necessitating immediate public health strategies to mitigate this trend. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Outcomes of Simultaneous Liver–Kidney Transplant Recipients According to Pre-Transplant Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the United States.

Author

Meier, Tristan, Schmidt, Kathryn, Cole, Kristin, Olson, Jody C., Taner, Timucin, Simonetto, Douglas A., and Riad, Samy

Abstract

Background: Previous data suggested that the outcomes for liver-alone transplant recipients following transjugular intrahepatic portosystemic shunt (TIPS) insertion were comparable to those without TIPS. This study investigates the association between TIPS and outcomes among simultaneous liver–kidney (SLK) recipients in the United States. Methods: Utilizing the Scientific Registry for Transplant Recipients (SRTR) standard analysis file from 2003 to 2022, we examined 9717 adult SLK recipients, among whom 858 had undergone TIPS before transplantation. Kaplan–Meier curves were generated to assess recipient and death-censored liver and kidney graft survival. Mixed-effects Cox proportional hazard models were employed to analyze the association between TIPS and the outcomes of interest, where the transplant center was treated as a random effect. The models were adjusted for recipient age, sex, MELD score, diabetes, duration of listing, induction, steroid maintenance, hepatitis C status, donor age, donor sex, cold ischemia time, local vs. shipped organs, and allocation era. Results: Overall, the two groups were comparable, with minor differences. Notably, the median liver waiting time was significantly longer in the TIPS group compared to the non-TIPS group (4.1 vs. 2 months, p < 0.001). One-year rejection rates for liver and kidney allografts did not differ significantly between groups. Univariable Cox regression analyses demonstrated no association between TIPS and worse outcomes for recipient, liver, and kidney survival (p = 0.65, p = 0.22, and p = 0.54, respectively). TIPS did not emerge as a predictor of recipient or death-censored liver or kidney graft survival in multivariable models. Conclusion: In this extensive national cohort of SLK transplant recipients, pre-transplant TIPS was not linked to adverse outcomes for recipients or their allografts. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium.

Author

Li, Xing, Ouyang, Tianqi, Belcher, Justin M., Patidar, Kavish R., Cullaro, Giuseppe, Asrani, Sumeet K., Wadei, Hani M., Simonetto, Douglas A., Regner, Kevin R., Dageforde, Leigh A., Przybyszewski, Eric M., Wilechansky, Robert M., Sharma, Pratima, Ufere, Nneka N., Duarte-Rojo, Andres, Wahid, Nabeel A., Orman, Eric S., St. Hillien, Shelsea A., Robinson, Jevon E., and Chung, Raymond T.

Published
2024
Full Text
View/download PDF

38. Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis.

Author

Islam, Alvi Husni, Díaz, Luis Antonio, Idalsoaga, Francisco, Guizzetti, Leonardo, Mortuza, Rokhsana, Dunn, Winston, Singal, Ashwani K., Simonetto, Douglas, Ramirez-Cadiz, Carolina, Wei Zhang, Qian, Steve, Cabezas, Joaquín, Sarin, Shiv K., Maiwall, Rakhi, Jalal, Prasun K., La Tijera, Fatima Higuera-De, Skladany, Lubomir, Bystrianska, Natalia, Rincon, Diego, and Chacko, Kristina R.

Published
2024
Full Text
View/download PDF

39. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.

Author

Dunn, Winston, Li, Yanming, Singal, Ashwani K., Simonetto, Douglas A., Díaz, Luis A., Idalsoaga, Francisco, Ayares, Gustavo, Arnold, Jorge, Ayala-Valverde, María, Perez, Diego, Gomez, Jaime, Escarate, Rodrigo, Fuentes-López, Eduardo, Ramirez-Cadiz, Carolina, Morales-Arraez, Dalia, Zhang, Wei, Qian, Steve, Ahn, Joseph C., Buryska, Seth, and Mehta, Heer

Published
2024
Full Text
View/download PDF

47. SAT-082 A phase 2 study of OCE-205, a novel, selective vasopressin receptor mixed agonist-antagonist: positive proof-of-concept established in subjects with cirrhosis and hepatorenal syndromeacute kidney injury (HRS-AKI)

Author

Allegretti, Andrew S., primary, Bajaj, Jasmohan, additional, Bari, Khurram, additional, Brown, Robert S., additional, Cullaro, Giuseppe, additional, Ganger, Daniel, additional, Hassanein, Tarek, additional, Kemmer, Nyingi, additional, Khemichian, Saro, additional, Yien Kwo, Paul, additional, Lim, Nicholas, additional, Naqvi, Hasan, additional, Patidar, Kavish, additional, Pyrsopoulos, Nikolaos T., additional, Rahimi, Robert S., additional, Rockey, Don, additional, Sanyal, Arun J., additional, Shetty, Kirti, additional, Simonetto, Douglas, additional, Stein, Lance, additional, Vargas, Hugo, additional, Zamor, Philippe, additional, Bernstein, David, additional, Kjems, Lise, additional, Lam, Jason, additional, Reid, Susan, additional, and Wong, Florence, additional

Published
2024
Full Text
View/download PDF

48. OS-038-YI Real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury-results from the ICA-GLOBAL AKI study

Author

Ma, Ann Thu, primary, Juanola, Adrià, additional, Patidar, Kavish, additional, Barone, Anna, additional, Incicco, Simone, additional, Kulkarni, Anand, additional, Pérez-Hernández, José Luis, additional, Wentworth, Brian, additional, Asrani, Sumeet, additional, Alessandria, Carlo, additional, Abdelkader, Nadia Abdelaaty, additional, Wong, Yu Jun, additional, Xie, Qing, additional, Pyrsopoulos, Nikolaos T., additional, Kim, Sung-Eun, additional, Fouad, Yasser, additional, Torre, Aldo, additional, Reyes, Eira Cerda, additional, Diaz-Ferrer, Javier, additional, Maiwall, Rakhi, additional, Simonetto, Douglas, additional, Papp, Maria, additional, Orman, Eric, additional, Perricone, Giovanni, additional, Solé, Cristina, additional, Lange, Christian M., additional, Farias, Alberto, additional, Pereira, Gustavo, additional, Gadano, Adrian, additional, Caraceni, Paolo, additional, Thévenot, Thierry, additional, Verma, Nipun, additional, Kim, Jeong Han, additional, Vorobioff, Julio D., additional, Cordova-Gallardo, Jacqueline, additional, Ivashkin, Vladimir, additional, Roblero, Juan Pablo, additional, Maan, Raoel, additional, Toledo, Claudio, additional, Riggio, Oliviero, additional, Fassio, Eduardo, additional, Marino, Mónica, additional, Nabilou, Puria, additional, Vargas, Victor, additional, Merli, Manuela, additional, Goncalves, Luciana Lofego, additional, Rabinowich, Liane, additional, Krag, Aleksander, additional, Balcar, Lorenz, additional, Montes, Pedro, additional, Mattos, Angelo Z., additional, Bruns, Tony, additional, Nur, Abdulsemed Mohammed, additional, Laleman, Wim, additional, Estupiñan, Enrique Carrera, additional, Cabrera, Maria Cecilia, additional, Girala, Marcos, additional, Samant, Hrishikesh, additional, Raevens, Sarah, additional, Madaleno, Joao, additional, Kim, W. Ray, additional, Arab, Juan Pablo, additional, Presa, José, additional, Ferreira, Carlos Noronha, additional, Galante, Antonio, additional, Roux, Olivier, additional, Allegretti, Andrew S., additional, Takkenberg, R. Bart, additional, Harputluoglu, Murat, additional, Marciano, Sebastián, additional, Sarin, Shiv Kumar, additional, Ginès, Pere, additional, Angeli, Paolo, additional, Solà, Elsa, additional, and Piano, Salvatore, additional

Published
2024
Full Text
View/download PDF

49. Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population

Author

Reddy, K. Rajender, primary, Weinberg, Ethan M., additional, Gonzalez, Stevan A., additional, Izzy, Manhal J., additional, Simonetto, Douglas A., additional, Frederick, R. Todd, additional, Rubin, Raymond A., additional, Fricker, Zachary, additional, Ikahihifo-Bender, Jade, additional, Harte, Maggie, additional, Garcia, Sandra, additional, Campbell, Kathryn, additional, Olofson, Amy, additional, Razavi, Ryan F., additional, James, Janelle M., additional, Patel, Het, additional, Kim-Lee, Grace, additional, Witkiewicz, Sherry, additional, Tobin, William, additional, and Jamil, Khurram, additional

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results